Aptose Biosciences, Inc. (APTO) financial statements (2021 and earlier)

Company profile

Business Address 251 CONSUMERS ROAD
TORONTO, ON M2J 4R3
State of Incorp. ON
Fiscal Year End December 31
SIC 2836 - Biological Products, Except Diagnostic Substances (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2019
Q4
9/30/2019
Q3
6/30/2019
Q2
3/31/2019
Q1
12/31/2018
Q4
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments98303517 
Cash and cash equivalents80212717 
Short-term investments181080 
Prepaid expense1011 
Other current assets0000 
Total current assets:99313618 
Noncurrent Assets
Operating lease, right-of-use asset1122
Property, plant and equipment0000 
Total noncurrent assets:2222 
TOTAL ASSETS:100323820 
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities5332 
Accounts payable2111 
Accrued liabilities3211 
Debt1100 
Total current liabilities:6433 
Noncurrent Liabilities
Long-term debt and lease obligation1111 
Operating lease, liability1111
Total noncurrent liabilities:1111 
Total liabilities:7544 
Stockholders' equity
Stockholders' equity attributable to parent94273415 
Common stock365291291267 
Additional paid in capital35353434 
Accumulated other comprehensive loss(4)(4)(4)(4) 
Accumulated deficit(302)(294)(287)(281) 
Total stockholders' equity:94273415 
TOTAL LIABILITIES AND EQUITY:100323820 

Income statement (P&L) ($ in millions)

12/31/2019
Q4
9/30/2019
Q3
6/30/2019
Q2
3/31/2019
Q1
12/31/2018
Q4
Operating expenses(8)(7)(6)(6) 
Operating loss:(8)(7)(6)(6) 
Nonoperating income0000 
Investment income, nonoperating 000 
Net loss available to common stockholders, diluted:(8)(7)(6)(6) 

Comprehensive Income ($ in millions)

12/31/2019
Q4
9/30/2019
Q3
6/30/2019
Q2
3/31/2019
Q1
12/31/2018
Q4
Net loss:(8)(7)(6)(6) 
Other comprehensive income0  0 
Comprehensive loss:(8)(7)(6)(5) 
Other undisclosed comprehensive income (loss), net of tax, attributable to parent (0)0  
Comprehensive loss, net of tax, attributable to parent:(8)(7)(6)(5) 

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: